子宫内膜异位症保留生育功能术后药物治疗的有效性与安全性:一项网络Meta分析
该网络Meta分析纳入16项随机对照试验共1605名20-45岁女性,比较10种保留生育功能腹腔镜术后药物。左炔诺孕酮宫内缓释系统(LNG-IUS)显著降低复发率(OR 0.12,95%CI 0.02-0.63),VAS疼痛评分降幅最大(MD -24.96,95%CI -41.76至-8.75)。达那唑增加体重增加风险,戈舍瑞林增加潮热风险。
要点
- LNG-IUS显著降低术后复发率(OR 0.12,95%CI 0.02-0.63)且VAS疼痛降幅最大。
- 达那唑显著增加体重增加,戈舍瑞林增加潮热,需谨慎使用。
- 共纳入16项RCT(n=1605),评估10种术后药物,随访至少2个月。
核心结论
- LNG-IUS联合腹腔镜手术在降低子宫内膜异位症患者复发和疼痛方面似乎最有效。
- 达那唑和戈舍瑞林因明显不良反应应谨慎使用。
研究设计与样本
- 系统检索PubMed、Web of Science、CENTRAL和Embase数据库至2024年8月1日。
- 纳入16项随机对照试验,共1605名20-45岁保留生育功能腹腔镜术后女性。
- 比较单药术后药物治疗,随访至少2个月,采用ROB 2.0和CINeMA评估质量,进行贝叶斯网络Meta分析。
主要发现
- LNG-IUS显著降低复发率(OR 0.12,95%CI 0.02-0.63)。
- LNG-IUS的VAS疼痛评分降幅最大(MD -24.96,95%CI -41.76至-8.75)。
- 达那唑显著增加体重增加,戈舍瑞林增加潮热。
关键数值与推荐
- 纳入标准:20-45岁女性,保留生育功能腹腔镜术后,比较单药术后药物治疗,随访至少2个月。
- 评估药物包括:达那唑、去氧孕烯、地诺孕素、孕三烯酮、戈舍瑞林、亮丙瑞林、LNG-IUS、甲羟孕酮、口服避孕药和曲普瑞林。
临床怎么用
- 原文结论认为LNG-IUS联合腹腔镜手术在降低复发和疼痛方面似乎最有效。
- 原文结论指出达那唑和戈舍瑞林因明显不良反应应谨慎使用。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Endometriosis (EMs) is a common gynaecological condition with high recurrence rates after fertility-preserving laparoscopic surgery, and optimal postoperative medical treatment remains unclear. OBJECTIVES: To evaluate the efficacy and safety of various postoperative medical treatments in reducing recurrence, pain and adverse events in EMs patients after fertility-preserving surgery. SEARCH STRATEGY: PubMed, Web of Science, CENTRAL and Embase databases searched until August 1, 2024. SELECTION CRITERIA: Randomised controlled trials (RCTs) involving women aged 20-45 years post-fertility-preserving laparoscopic surgery, comparing single postoperative medications with a minimum follow-up of 2 months. DATA COLLECTION AND ANALYSIS: Two reviewers independently extracted data and assessed quality using ROB 2.0 and CINeMA. Bayesian network meta-analysis calculated odds ratios (OR) and mean differences (MD) for recurrence rates, VAS pain reduction and adverse events. MAIN RESULTS: Sixteen RCTs (n = 1605 participants) evaluated 10 drugs: danazol, desogestrel, dienogest, gestrinone, goserelin, leuprolide, LNG-IUS, medroxyprogesterone, oral contraceptives and triptorelin. Only LNG-IUS significantly reduced recurrence rates (OR 0.12, 95% CI 0.02-0.63) and showed the greatest reduction in VAS pain scores (MD -24.96, 95% CI -41.76 to -8.75). Danazol significantly increased weight gain, and goserelin increased hot flashes. CONCLUSIONS: LNG-IUS combined with laparoscopic surgery appears most effective in reducing recurrence and pain in EMs patients. Danazol and goserelin should be used cautiously due to notable adverse effects.
引用
- Xiong Y, Huang W, Wang C, et al. Effectiveness and Safety of Postoperative Medical Treatments Following Fertility-Preserving Surgery for Endometriosis: A Network Meta-Analysis. BJOG. 2025. PMID: 41017486. doi:10.1111/1471-0528.70016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。